Interaction of smoking and atopy in producing specific IgE antibody against a hapten protein conjugate.
K M Venables, M D Topping, W Howe, C M Luczynska, R Hawkins, A J Taylor
Index: Br. Med. J. (Clin. Res. Ed.) 290(6463) , 201-4, (1985)
Full Text: HTML
Abstract
A survey was carried out of a population of workers exposed to tetrachlorophthalic anhydride, an acid anhydride epoxy resin curing agent known to cause asthma. Using a radioallergosorbent test with a tetrachlorophthalic anhydride human serum albumin conjugate, specific IgE antibody was detected in serum from 24 out of 300 factory floor workers exposed to tetrachlorophthalic anhydride. Of these 24, 20 (83.3%) were current smokers compared with 133 (48.2%) of 276 without antibody (p less than 0.01), and there was a weaker association with atopy, defined by skin tests with common allergens. Smoking and atopy interacted, the prevalence of antibody being 16.1% in atopic smokers, 11.7% in non-atopic smokers, 8.3% in atopic non-smokers, and nil in non-atopic non-smokers (p less than 0.025). Smoking may predispose to, and interact with atopy in, the production of specific IgE antibody to this hapten protein conjugate.
Related Compounds
Related Articles:
Allergic reactions to industrial chemicals.
1983-01-01
[Clin. Immunol. Rev. 2(1) , 1-58, (1983)]
1991-01-01
[Clin. Exp. Allergy 21 Suppl 1 , 234-40, (1991)]
1993-06-01
[J. Lab. Clin. Med. 121(6) , 792-6, (1993)]
Tetrachlorophthalic anhydride asthma: evidence for specific IgE antibody.
1983-01-01
[J. Allergy Clin. Immunol. 71(1 Pt 1) , 5-11, (1983)]
1987-08-01
[J. Allergy Clin. Immunol. 80(2) , 212-8, (1987)]